의료용 전문 백 시장 규모, 점유율, 동향 및 예측 : 제품별, 최종사용자별, 지역별(2026-2034년)

The global medical specialty bags market size was valued at USD 12.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 17.6 Billion by 2034, exhibiting a CAGR of 3.76% from 2026-2034. North America currently dominates the medical specialty bags market share by holding over 32.8% in 2025. The market is driven by advanced healthcare infrastructure, high prevalence of chronic diseases, growing geriatric population, increasing surgical procedures, and favorable reimbursement policies in the region.

The growth of the global medical specialty bags market is mainly fueled by the increasing prevalence of chronic diseases like diabetes, kidney disorders, and cancer, which drive the demand for intravenous (IV) therapy, dialysis, and blood transfusion bags. The rising geriatric population requires long-term medical care, which is boosting demand for ostomy and urinary collection bags. Moreover, ongoing advancements in healthcare infrastructure and hospital expansions enhance accessibility to specialized medical products, contributing to the market expansion. For instance, in March 2025, India's Zydus Lifesciences announced plans to acquire an 85.6% stake in France's Amplitude Surgical for €256.8 million, aiming to expand its presence in the global medical devices market, further strengthening the supply chain for medical specialty bags. Besides this, favorable reimbursement policies encourage patient adoption, driving the market growth. Furthermore, the increasing number of surgical procedures globally drives the market demand for sterile medical bags. Also, continuous innovation in eco-friendly and polyvinyl chloride (PVC)-free medical bags aligns with sustainability goals, thus impelling the market growth.

The United States medical specialty bags market demand is currently exhibiting a total share of 90.60% and is driven by various factors. High hospitalization rates due to lifestyle-related diseases, such as obesity and cardiovascular disorders, increase demand for IV and blood transfusion bags, boosting the market growth. In confluence with this, the rising outpatient and home healthcare services drive the need for user-friendly and portable medical bags, which is providing an impetus to the market. Concurrently, stringent Food and Drug Administration (FDA) regulations ensure high-quality, innovative products, encouraging manufacturers to invest in research and development (R&D), and supporting the market growth. For example, in 2024, the Centers for Disease Control and Prevention (CDC) released the 2024 National Healthcare Safety Network (NHSN) Patient Safety Component Manual, guiding infection control practices that involve the use of medical specialty bags. Also, the growing military and veteran healthcare programs expand the demand for specialized medical supplies, providing an impetus to the market. Furthermore, ongoing technological advancements in smart monitoring medical bags improve patient safety, impelling the market demand. Apart from this, the increasing awareness of infection control accelerates the adoption of sterile, single-use medical bags, thereby propelling the market forward.

MEDICAL SPECIALTY BAGS MARKET TRENDS:

Aging Population and Chronic Disease Prevalence

The increasing health consciousness due to the rising prevalence of various chronic diseases, mostly amongst the rising geriatric population, represents one of the prime factors currently driving the medical specialty bags market growth. According to the World Health Organization (WHO), projections estimate that 1 out of 6 worldwide population will reach age 60 years and above by 2030. This is further supported by the increasing need for customer-focused products and services, which, in turn, is facilitating widespread product adoption across the globe. Additionally, the growing demand for long-term care solutions, continuous advancements in home healthcare, and improved accessibility to high-quality medical supplies are strengthening the medical specialty bags market share. Moreover, these technological innovations in medical specialty bags, including lightweight, leak-proof, and eco-friendly designs, are enhancing their usability among aging patients with chronic conditions.

Government Initiatives and Healthcare Infrastructure Enhancement

Numerous favorable initiatives undertaken by the government bodies of several countries for strengthening the healthcare infrastructure and enhancing the medical standards through the employment of improved reimbursement packages are acting as major growth-inducing factors. According to the American Hospital Association, in 2025, there are approximately 6,093 hospitals in the United States. Additionally, increased government funding for advanced medical technologies, expansion of healthcare facilities in rural areas, and policies promoting local manufacturing of medical devices are driving the market growth. Furthermore, public-private partnerships and regulatory reforms aimed at ensuring patient safety and accessibility to high-quality medical specialty bags are enhancing the medical specialty bags market outlook.

Material Innovation and Increasing Demand for IV Therapy Bags

The escalating demand for PVC bags in the healthcare sector on account of their versatility, affordability, and recyclability qualities is influencing the medical specialty bags market trends. In line with this, the extensive utilization of IV therapy bags in several applications, such as surgeries, providing nutrition to patients, sustaining basal hydration levels, and maintaining the correct electrolyte balance, is propelling the market growth. For instance, Australia secured a $40 million deal to expand onshore manufacturing of IV saline fluids, aiming to produce at least 80 million units annually by 2027, reducing reliance on international supplies. Besides this, factors such as strategic collaborations between key players and continuous investments in R&D activities in the field of medical science for introducing advanced medical tools and accessories, are creating a positive outlook for the market. Additionally, the rising preference for non-PVC alternatives, increased demand for single-use medical bags to prevent infections, and the growing adoption of smart IV bags with monitoring features are driving innovation and contributing to the market expansion.

MEDICAL SPECIALTY BAGS INDUSTRY SEGMENTATION:

Analysis by Product:

• Anesthesia Breathing Bags
• Blood Bags
• Sterile Packaging Bags
• Ostomy Collection Bags
• Enteral Feeding Bags
• Cadaver Bags
• Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
• Intravenous Fluid Bags
• Others

Ostomy collection bags hold the largest market share, accounting for 27.5% in 2025. This segment is driven by the rising prevalence of colorectal cancer, inflammatory bowel diseases, and a growing geriatric population requiring ostomy procedures. In addition to this, ongoing technological advancements in ostomy care products such as skin-friendly adhesives and odor control technologies are improving patient comfort and adoption rates. Moreover, the growing awareness, better reimbursement policies, and ostomy patient support programs are fostering the market growth. Concurrently, growth in home healthcare services and demand for low-key, easy-to-use products support the dominance of the segment. Furthermore, the emphasis by producers on light, long-lasting, and environmentally friendly materials, fuels innovation, thereby strengthening the market share.

Analysis by End User:

• Hospitals
• Ambulatory Surgical Centers
• Home Healthcare
• Others

Hospitals lead the medical specialty bags market with a share of 55.0% in 2025. This segment is driven by the increasing number of surgical procedures, rising hospital admissions due to chronic diseases, and the growing geriatric population requiring long-term medical care. In line with this, having a well-developed healthcare infrastructure, hospitals are central locations for IV therapy, dialysis, blood transfusions, and ostomy care, all of which depend on specialty medical bags. The demand is also driven by infection control needs, strict regulatory requirements, and hospital-acquired infection (HAI) prevention protocols, to ensure the utilization of high-quality, sterile medical bags. Besides this, government efforts to upgrade healthcare facilities, positive reimbursement policies, and improvements in hospital-based medical technologies are supporting the market growth. Moreover, the growing use of single-use, environment-friendly, and recyclable medical bags to ensure patient safety and sustainability further supports the leadership of hospitals in the global market.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2025, North America accounted for the largest share of the medical specialty bags market by holding a significant share of 32.8%. The demand in this region is fueled by a well-developed healthcare infrastructure, a high incidence of chronic conditions, and an increasing elderly population necessitating long-term medical therapy. Additionally, strong government support, favorable reimbursement policies, and cutting-edge medical technologies strengthen demand for products of IV therapy, blood transfusions, and ostomy care. In conjunction with this, the availability of top-ranking medical device firms, steady investment in R&D, and expanding hospital admissions are bolstering the market growth. However, challenges such as supply chain disruptions have also impacted the industry. For example, in 2024, Hurricane Helene severely damaged Baxter International's North Carolina facility, responsible for 60% of U.S. IV fluid production, leading to nationwide shortages. To tackle this, Baxter initiated phased restorations of its affected plant, aiming to meet 90-100% of customer needs by year's end. Concurrently, the company planned to import 18,000 tons of IV products from international sites, utilizing around 200 Boeing 747 flights. Furthermore, the increasing knowledge related to infection prevention and a tendency towards eco-compliant single-use medical bags supplement growth is significantly propelling the market forward.

KEY REGIONAL TAKEAWAYS:

UNITED STATES MEDICAL SPECIALTY BAGS MARKET ANALYSIS

The United States is experiencing a surge in medical specialty bags demand, fueled by substantial investment in the healthcare sector. According to reports, in the US pharmaceutical industry, there were 25 private equity deals announced in Q3 2024, worth a total value of USD 2.3 Billion. The expansion of hospitals, clinics, and outpatient centers is increasing the need for advanced storage, collection, and fluid management solutions. Rising healthcare spending is accelerating technological advancements, leading to the development of improved designs that cater to diverse medical requirements. Growing focus on patient care and infection control measures is driving the usage of specialized products across surgical, home care, and diagnostic applications. Favorable reimbursement policies and regulatory approvals are further strengthening the adoption of disposable and reusable solutions, ensuring hygiene and efficiency in medical procedures. Increasing awareness among healthcare professionals regarding the benefits of high-quality materials and leak-proof designs is propelling market growth. Advancements in medical research and innovation in biopharmaceuticals are also contributing to the expansion of applications, making these products an essential part of modern healthcare.

EUROPE MEDICAL SPECIALTY BAGS MARKET ANALYSIS

Europe is witnessing a rising demand for medical specialty bags, driven by the increasing geriatric population. According to WHO, the population aged 60 and older is rapidly growing in the WHO European Region. Research shows that the global diabetic population reached 215 Million in 2021 and forecasts a projected growth to 247 Million by 2030 before surpassing 300 Million by 2050. Aging individuals require advanced healthcare solutions for chronic conditions, post-surgical recovery, and long-term treatments, boosting the need for effective fluid management and collection products. The growing prevalence of age-related disorders, including urological and cardiovascular conditions, is leading to a higher adoption of specialized drainage and storage solutions. Healthcare providers are prioritizing sterile, disposable, and reusable options to enhance patient care and reduce infection risks. The demand for home care solutions is rising, as elderly individuals prefer convenient and reliable medical support outside hospital settings. Innovations in material technology and manufacturing processes are improving product durability and patient comfort. The expansion of specialized clinics and rehabilitation centers is fostering the need for high-quality solutions tailored to geriatric healthcare.

ASIA PACIFIC MEDICAL SPECIALTY BAGS MARKET ANALYSIS

Asia-Pacific is witnessing rapid growth in medical specialty bags demand, supported by expanding healthcare infrastructure. For instance, India has nearly 70,000 operational hospitals, 63% privately owned; the remaining 37% are government-owned. Continuous investment in new hospitals, diagnostic centers, and surgical facilities is creating opportunities for advanced fluid collection and drainage solutions. Governments and private organizations are actively enhancing medical service accessibility, contributing to the increasing adoption of cost-effective and high-quality products. Rising awareness about hygiene and safety in medical procedures is pushing hospitals and clinics to prioritize disposable and sterile options. The development of emergency care units and specialized treatment centers is strengthening demand across surgical and chronic disease management applications. Technological advancements and localization of manufacturing processes are improving product availability, making these solutions more affordable and accessible. Increasing focus on modernizing healthcare services and integrating high-efficiency medical equipment is driving innovations in material composition and design.

LATIN AMERICA MEDICAL SPECIALTY BAGS MARKET ANALYSIS

Latin America is seeing an increase in medical specialty bags usage due to urbanization and rising disposable income. For instance, 85.2 % of the Latin America population is urban (565,084,260 people in 2024). Expanding metropolitan areas are strengthening access to healthcare services, leading to a higher demand for surgical and diagnostic solutions. Economic growth is enabling individuals to invest in quality medical treatments, increasing the adoption of advanced fluid collection and drainage systems. Improved access to private healthcare services is also supporting demand, as hospitals and clinics prioritize efficient and hygienic patient care. Increasing awareness of infection control practices is further promoting the use of single-use and sterilized solutions in healthcare settings.

MIDDLE EAST AND AFRICA MEDICAL SPECIALTY BAGS MARKET ANALYSIS

Middle East and Africa are witnessing growing adoption of medical specialty bags due to expanding healthcare facilities. According to the Dubai Healthcare City Authority report, Dubai's healthcare sector saw rapid growth, with 4,482 private medical facilities and 55,208 licensed professionals by 2022, projected to expand further by 3-6% in facilities and 10-15% in professionals in 2023. New hospitals, surgical centers, and diagnostic labs are driving demand for reliable storage and drainage products. Increasing government and private sector investments in healthcare infrastructure are enhancing accessibility to medical treatments, contributing to market expansion. The need for high-quality patient care and infection control measures is supporting the usage of sterile and disposable solutions.

COMPETITIVE LANDSCAPE:

The global medical specialty bags market is highly competitive, with key players focusing on product innovation, strategic mergers, and geographic expansion to strengthen their market presence. Companies are investing in R&D to introduce advanced, patient-friendly, and eco-conscious medical bags, such as PVC-free and biodegradable alternatives. Partnerships with hospitals and healthcare providers are increasing to enhance product accessibility. Additionally, regulatory approvals and compliance with stringent healthcare standards remain crucial for market players. Major companies are expanding production facilities and enhancing supply chain efficiency to meet rising demand. Also, digitalization, automation in manufacturing, and smart monitoring solutions for IV and ostomy bags are emerging trends shaping the competitive landscape.

The report provides a comprehensive analysis of the competitive landscape in the medical specialty bags market with detailed profiles of all major companies, including:

• Ambu A/S
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Coloplast A/S
• ConvaTec Group PLC
• Hollister Incorporated
• Macopharma
• Medline Industries LP
• Nolato AB
• Pall Corporation (Danaher Corporation)
• SB-Kawasumi Laboratories Inc. (Sumitomo Bakelite Co. Ltd.)
• Terumo Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the medical specialty bags market?

2. What is the future outlook of the medical specialty bags market?

3. What are the key factors driving the medical specialty bags market?

4. Which region accounts for the largest medical specialty bags market share?

5. Which are the leading companies in the global medical specialty bags market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Specialty Bags Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Anesthesia Breathing Bags
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Blood Bags
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Sterile Packaging Bags
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Ostomy Collection Bags
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Enteral Feeding Bags
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Cadaver Bags
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast
• 6.8 Intravenous Fluid Bags
  • 6.8.1 Market Trends
  • 6.8.2 Market Forecast
• 6.9 Others
  • 6.9.1 Market Trends
  • 6.9.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Ambulatory Surgical Centers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Home Healthcare
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Ambu A/S
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 B. Braun Melsungen AG
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 SWOT Analysis
  • 13.3.3 Baxter International Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Becton Dickinson and Company
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Coloplast A/S
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 ConvaTec Group PLC
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
  • 13.3.7 Hollister Incorporated
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 SWOT Analysis
  • 13.3.8 Macopharma
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 Medline Industries LP
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 SWOT Analysis
  • 13.3.10 Nolato AB
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
  • 13.3.11 Pall Corporation (Danaher Corporation)
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 SWOT Analysis
  • 13.3.12 SB-Kawasumi Laboratories Inc. (Sumitomo Bakelite Co. Ltd.)
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
  • 13.3.13 Terumo Corporation
    • 13.3.13.1 Company Overview
    • 13.3.13.2 Product Portfolio
    • 13.3.13.3 Financials
    • 13.3.13.4 SWOT Analysis